Maryland bills · 2026 Regular Session
Maryland HB 417
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Woorman (Democratic)
- White Holland (Democratic)
- Taveras (Democratic)
- Szeliga (Republican)
- Ross (Democratic)
- Rosenberg (Democratic)
- Reilly (Republican)
- M. Morgan (Republican)
- Martinez
- Lopez (Democratic)
- Kipke (Republican)
- Kaufman (Democratic)
- S. Johnson (Democratic)
- Hutchinson (Republican)
- Hill (Democratic)
- Guzzone (Democratic)
- Cullison (Democratic)
- Bagnall (Democratic)
- Alston (Democratic)
- Kerr (Democratic)
- Pippy (Republican)
Summary
No official summary is available for this bill.
Latest action(Apr 13, 2026): Motion Special Order until Next Session (Senator Love) Adopted
Text versions
- Third - Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
- First - Public Health - Medetomidine and Xylazine Consumer Protection Act
Roll-call votes
State vote data last updated Oct 15, 2026, 4:19 PM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Feb 23, 2026 House | On Third Reading | pass | Set your home in Maryland to see |
Actions
- Apr 13, 2026 · Senate
Motion Special Order until Next Session (Senator Love) Adopted - Apr 13, 2026 · Senate
Favorable - Apr 13, 2026 · Senate
Favorable Report by Finance - Mar 5, 2026 · Senate
Referred Finance - Mar 4, 2026 · House
Third Reading Passed - Mar 3, 2026 · House
Second Reading Passed with Amendments - Mar 3, 2026 · House
Favorable with Amendments { - Mar 3, 2026 · House
Favorable with Amendments Report by Health - Feb 10, 2026 · House
Hearing 2/10 at 2:30 p.m. - Feb 10, 2026 · House
Hearing canceled - Jan 22, 2026 · House
Hearing 2/10 at 2:00 p.m. - Jan 22, 2026 · House
First Reading Health